Huaxia Eye Hospital Stock Current Valuation
| 301267 Stock | 20.44 0.26 1.29% |
Valuation analysis of Huaxia Eye Hospital helps investors to measure Huaxia Eye's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Fundamental drivers impacting Huaxia Eye's valuation include:
Price Book 3.0388 | Enterprise Value 14.8 B | Enterprise Value Ebitda 19.9062 | Price Sales 4.247 | Trailing PE 37.746 |
Undervalued
Today
Please note that Huaxia Eye's price fluctuation is not too volatile at this time. Calculation of the real value of Huaxia Eye Hospital is based on 3 months time horizon. Increasing Huaxia Eye's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Huaxia Eye is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Huaxia Stock. However, Huaxia Eye's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.44 | Real 21.8 | Hype 21.71 |
The real value of Huaxia Stock, also known as its intrinsic value, is the underlying worth of Huaxia Eye Hospital Company, which is reflected in its stock price. It is based on Huaxia Eye's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Huaxia Eye's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Huaxia Eye Hospital helps investors to forecast how Huaxia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Huaxia Eye more accurately as focusing exclusively on Huaxia Eye's fundamentals will not take into account other important factors: Huaxia Eye Hospital Company Current Valuation Analysis
Huaxia Eye's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Huaxia Eye Current Valuation | 14.82 B |
Most of Huaxia Eye's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Huaxia Eye Hospital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Huaxia Eye Hospital has a Current Valuation of 14.82 B. This is 3.18% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 10.85% higher than that of the company.
Huaxia Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Huaxia Eye's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Huaxia Eye could also be used in its relative valuation, which is a method of valuing Huaxia Eye by comparing valuation metrics of similar companies.Huaxia Eye is currently under evaluation in current valuation category among its peers.
Huaxia Fundamentals
| Return On Equity | 0.0946 | ||||
| Return On Asset | 0.0562 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 14.82 B | ||||
| Shares Outstanding | 840 M | ||||
| Shares Owned By Insiders | 84.28 % | ||||
| Shares Owned By Institutions | 5.19 % | ||||
| Price To Book | 3.04 X | ||||
| Price To Sales | 4.25 X | ||||
| Revenue | 4.09 B | ||||
| Gross Profit | 1.55 B | ||||
| EBITDA | 820.9 M | ||||
| Book Value Per Share | 6.96 X | ||||
| Earnings Per Share | 0.63 X | ||||
| Target Price | 39.75 | ||||
| Number Of Employees | 7.61 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 19.98 B | ||||
| Annual Yield | 0 % | ||||
| Last Dividend Paid | 0.11 |
About Huaxia Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Huaxia Eye Hospital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huaxia Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huaxia Eye Hospital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huaxia Stock
Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.